Clinical Trials Directory

Trials / Completed

CompletedNCT03648008

Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy

Postoperative Analgesic Effect of Hydromorphone on Chinese Patients Receiving Partial Pulmonary Resection Under Video-assisted Thoracoscopy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
171 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Postoperative pain remains relatively high within 48h for Chinese patients who receive video-assisted thoracoscopic surgery. Multimodal analgesia combines several agents and/or techniques to function on diverse nociceptive mechanisms to enhance pain relief and lessen side effect. Hydromorphone is a hydrogenated ketone of morphine and approximately 5-10 times more potent. There lacks about efficacy and efficiency of hydromorphone in electrical pump for patient controlled intravenous analgesic (PCIA).

Conditions

Interventions

TypeNameDescription
DRUGHydromorphone0.002 mg\*kg-1 bolus with 0.002 mg\*kg-1 background infusion for group BH 0.002 mg\*kg-1 bolus without background infusion for group NBH Drug is administered through PCIA pump.
DRUGMorphine0.015 mg\*kg-1 bolus without background infusion for group M Drug is administered through PCIA pump.

Timeline

Start date
2018-05-05
Primary completion
2018-09-01
Completion
2018-09-01
First posted
2018-08-27
Last updated
2018-09-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03648008. Inclusion in this directory is not an endorsement.

Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy (NCT03648008) · Clinical Trials Directory